Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC7058 | Amprenavir Featured |
Amprenavir (Agenerase) is a HIV protease inhibitor(Ki=0.6 nM) used to treat HIV infection.
More description
|
![]() |
DC9476 | NBD-556 Featured |
NBD-556 is small molecule mimetic of CD4, NBD-556 recognizes the HIV-1 envelope protein gp120 and induces restructuring of gp120 analogous to CD4 binding.
More description
|
![]() |
DC2046 | Cobicistat (GS-9350) Featured |
Cobicistat (GS-9350) is a potent and selective inhibitor of CYP3A with IC50 of 30-285 nM.
More description
|
![]() |
DC9475 | Ritonavir Featured |
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS,showed potent activity against COVID-19(SARS-COV-2) .
More description
|
![]() |
DC5902 | Emtricitabine Featured |
Emtricitabine is a nucleoside analogue which inhibits the reverse nucleoside transcriptase enzyme. Structurally this antiviral agent is similar to Lamivudine. This agent is effective at targeting HIV and HBV viruses since these viruses replicate in a reve
More description
|
![]() |
DC7336 | Vicriviroc maleate(Sch-417690) Featured |
Vicriviroc Malate is a potent CKR-5 (CCR5) antagonist with IC50 of 0.91 nM.
More description
|
![]() |
DC11397 | TAK-779 Featured |
TAK-779 is a potent and selective nonpeptide antagonist of CCR5 and CXCR3, with a Ki of 1.1 nM for CCR5, and effectively and selectively inhibits R5 HIV-1, with EC50 and EC90 of 1.2 nM and 5.7 nM, respectively, in MAGI-CCR5 cells.
More description
|
![]() |
DC7266 | Rilpivirine(R 278474, TMC 278) Featured |
Rilpivirine(R 278474, TMC 278) is a type of anti-HIV medicine called a non-nucleoside reverse transcriptase inhibitor (NNRTI).
More description
|
![]() |
DCAPI1581 | Raltegravir Featured |
Raltegravir Salt is a potent human immunodeficiency virus (HIV) integrase inhibitor and a novel anti-AIDS drug.
More description
|
![]() |
DC9019 | Nevirapine |
Nevirapine is a potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of HIV-1 infection and AIDS.
More description
|
![]() |
DC9308 | Doravirine (MK-1439) Featured |
Doravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor.
More description
|
![]() |
DCAPI1505 | Darunavir Featured |
Darunavir(TMC114) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2) .
More description
|
![]() |
DC10890 | Bictegravir Featured |
Bictegravir is a novel, potent inhibitor of HIV-1 integrase with an IC50 of 7.5 nM.
More description
|
![]() |
DC3150 | Atazanavir Featured |
Atazanavir is a HIV protease inhibitor with Ki of 2.66 nM.
More description
|
![]() |
DC8908 | Darunavir ethanolate Featured |
Darunavir ethanolate is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).
More description
|
![]() |
DC10355 | Nelfinavir Featured |
Nelfinavir(AG-1341) is a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor (Ki=2 nM) and is widely prescribed in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection.
More description
|
|
DC9700 | BMS-707035 Featured |
BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity.
More description
|
![]() |
DC7273 | Dolutegravir Featured |
Dolutegravir (DTG, GSK1349572) is an integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.
More description
|
![]() |
DC10250 | Dolutegravir Sodium Featured |
Dolutegravir is a HIV integrase inhibitor with IC50 of 2.7 nM.
More description
|
![]() |
DC7421 | GO 6976 Featured |
Go6976 is a potent PKC inhibitor with IC50 of 7.9 nM, 2.3 nM, and 6.2 nM for PKC (Rat brain), PKCα, and PKCβ1, respectively. Also a potent inhibitor of JAK2 and Flt3.
More description
|
![]() |
DC9474 | Nelfinavir (Mesylate) |
Nelfinavir(AG-1341) is a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor (Ki=2 nM) and is widely prescribed in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection.
More description
|
![]() |
DC9864 | Azidothymidine (AZT) |
Selective reverse transcriptase inhibitor. Exhibits 100-fold selectivity for HIV reverse transcriptase over DNA polymerase α.
More description
|
![]() |
DC8628 | Saquinavir Mesylate Featured |
Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy.
More description
|
![]() |
DC8627 | Saquinavir Featured |
Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy.
More description
|
![]() |
DC9479 | Raltegravir (potassium salt) |
Raltegravir potassium salt(MK0518 potassium salt) is a potent integrase (IN) inhibitor, used to treat HIV infection.
More description
|
![]() |
DC9477 | NBD-557 |
NBD-557 is a potentially HIV-1 inhibitor.
More description
|
![]() |
DC4234 | Etravirine |
Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1).
More description
|
![]() |
DCAPI1479 | Efavirenz |
Efavirenz is a nonnucleoside HIV-1 reverse transcriptase (RT) inhibitor which selectively inhibits the glucuronidation of 3'-Azido-3'-deoxythymidine β-D-glucuronide, Sodium Salt. Studies suggest that Efavirenz binds to a distinct site of reverse transcrip
More description
|
![]() |
DC8897 | Delavirdine |
Delavirdine(U 90152) is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).
More description
|
![]() |
DC11352 | Delavirdine (mesylate) |
Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that selectively inhibits HIV-1 reverse transcriptase over DNA polymerase α and δ in vitro (IC50s = 0.26, 440, and >550 μM, respectively).
More description
|
![]() |